STOCK TITAN

United Therapeutics Corp. Stock Price, News & Analysis

UTHR Nasdaq

Welcome to our dedicated page for United Therapeutics news (Ticker: UTHR), a resource for investors and traders seeking the latest updates and insights on United Therapeutics stock.

United Therapeutics Corporation (UTHR) delivers innovative therapies for pulmonary arterial hypertension and rare diseases through cutting-edge research and targeted drug development. This news hub provides investors, healthcare professionals, and stakeholders with timely updates on regulatory milestones, clinical trial progress, and strategic initiatives shaping the biopharmaceutical landscape.

Access verified press releases, financial disclosures, and scientific advancements in one centralized location. Our curated collection features updates on treprostinil-based treatments, FDA approvals, partnership announcements, and R&D pipeline developments – all essential for tracking UTHR's progress in addressing unmet medical needs.

Discover comprehensive coverage spanning earnings reports, manufacturing expansions, and therapeutic innovations. Content is rigorously vetted to ensure accuracy and relevance for both expert analysts and general readers seeking reliable information about this biotechnology leader.

Bookmark this page for streamlined access to United Therapeutics' latest developments. Check back regularly to stay informed about critical updates impacting patient care and investment considerations in the specialized pharmaceutical sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.79%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.42%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
conferences

FAQ

What is the current stock price of United Therapeutics (UTHR)?

The current stock price of United Therapeutics (UTHR) is $308 as of May 8, 2025.

What is the market cap of United Therapeutics (UTHR)?

The market cap of United Therapeutics (UTHR) is approximately 13.7B.
United Therapeutics Corp.

Nasdaq:UTHR

UTHR Rankings

UTHR Stock Data

13.67B
44.09M
1.83%
100.81%
5.49%
Biotechnology
Pharmaceutical Preparations
Link
United States
SILVER SPRING